Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test, Sinus headache, Tremor
Clinical narrative: Booster dose: Fatigue; Booster dose: nausea; Booster dose: really bad headache, almost like a; almost like a sinus headache; Booster dose: fever; Booster dose: Chills at night, her body was shaking; Booster dose: Chills at night, her body was shaking; Booster dose: lymph node swelling under her arm; Booster dose: bone aches; Received the Pfizer-BioNTech COVID-19 Vaccine booster dose; complete loss of sense of taste and smell; complete loss of sense of taste and smell; nose full of gunk and mucus and blood; "Nose full of gunk and mucus and blood" with a "dry sticky consistency in the morning"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 44 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0187), administered in arm right, administration date 29Mar2021 at the age of 44 years as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU VACCINE VII; TDAP. Vaccination history included: BNT162B2 (DOSE 1, Lot no ER8734, Left arm), administration date: 29Mar2021, for Covid-19 Immunization; Bnt162b2 (DOSE 2, Lot no ER8737, Left arm), administration date: 19Apr2021, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Received the Pfizer-BioNTech COVID-19 Vaccine booster dose"; AGEUSIA (non-serious), ANOSMIA (non-serious) all with onset Nov2021, outcome "not recovered" and all described as "complete loss of sense of taste and smell"; EPISTAXIS (non-serious) with onset Nov2021, outcome "not recovered", described as "nose full of gunk and mucus and blood"; NASAL DRYNESS (non-serious) with onset Nov2021, outcome "not recovered", described as ""Nose full of gunk and mucus and blood" with a "dry sticky consistency in the morning""; FATIGUE (non-serious), outcome "unknown", described as "Booster dose: Fatigue"; NAUSEA (non-serious), outcome "unknown", described as "Booster dose: nausea"; HEADACHE (non-serious), outcome "not recovered", described as "Booster dose: really bad headache, almost like a"; SINUS HEADACHE (non-serious), outcome "not recovered", described as "almost like a sinus headache"; PYREXIA (non-serious), outcome "unknown", described as "Booster dose: fever"; CHILLS (non-serious), TREMOR (non-serious), outcome "unknown" and all described as "Booster dose: Chills at night, her body was shaking"; LYMPHADENITIS (non-serious), outcome "unknown", described as "Booster dose: lymph node swelling under her arm"; BONE PAIN (non-serious), outcome "unknown", described as "Booster dose: bone aches". The events "complete loss of sense of taste and smell", "complete loss of sense of taste and smell", "nose full of gunk and mucus and blood" and ""nose full of gunk and mucus and blood" with a "dry sticky consistency in the morning"" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.